Alnylam Pharmaceuticals | Passività Correnti



Current Liabilities Cambiamento Data
Acadia Pharmaceuticals USD 330.02M 27.49M 2025-06
Agios Pharmaceuticals USD 70.41M 18.04M 2025-06
Alnylam Pharmaceuticals USD 1.3B 225.22M 2025-06
Amgen USD 20.48B 2.53B 2025-06
Arrowhead Research USD 194.53M 26.01M 2025-06
BioMarin Pharmaceutical USD 684.25M 56.03M 2025-06
Incyte USD 1.28B 608.18M 2025-06
Ionis Pharmaceuticals USD 897.24M 646.94M 2025-06
Moderna USD 1.57B 32M 2025-06
Neurocrine Biosciences USD 546.3M 23.4M 2025-06
Novartis USD 28.69B 560M 2024-12
PTC Therapeutics USD 627.81M 32.42M 2025-06
Regeneron Pharmaceuticals USD 3.67B 100.4M 2025-06
Sanofi 29.16B 865M 2024-12
Sarepta Therapeutics USD 919.95M 314.36M 2025-06
Takeda JPY 2.17T 336.94B 2025-06
Tectonic Therapeutic USD 11.61M 5.71M 2024-12
Ultragenyx Pharmaceutical USD 293.24M 1.58M 2025-06
Vertex Pharmaceuticals USD 4.14B 355.2M 2025-06
Xencor USD 96.08M 7.65M 2025-06


Alnylam Pharmaceuticals Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.